Cardlytics
CDLX
189 hedge funds and large institutions have $3.99B invested in Cardlytics in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 68 reducing their positions, and 46 closing their positions.
41% more call options, than puts
Call options by funds: $17.2M | Put options by funds: $12.2M
19% more capital invested
Capital invested by funds: $3.35B → $3.99B (+$635M)
0.09% less ownership
Funds ownership: 9.63% → 9.54% (-0.09%)
7% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 68
7% less funds holding
Funds holding: 204 → 189 (-15)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
30% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$142M |
| 2 |
6CM
683 Capital Management
New York
|
+$59.9M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
+$38.2M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$37.7M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$20.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$45.7M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$39.6M |
| 3 |
Morgan Stanley
New York
|
-$31.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$21.7M |
CDLX Hedge Fund Activity: Q2 2021 in Review
189 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2021, worth a combined $3.99B — up 19% from $3.35B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of CDLX and 32 opened new positions — a net loss of 14 holders — while 68 trimmed existing stakes and 63 added.
The largest buyer was Wellington Management Group, adding an estimated $142M. The largest seller was Wells Fargo, cutting an estimated $45.7M.
- 189 institutional investors held Cardlytics (CDLX) as of Q2 2021, down from 204 in Q1 2021.
- Funds reported $3.99B of Cardlytics stock for Q2 2021, up 19% quarter-over-quarter.
- 32 funds opened new Cardlytics positions in Q2 2021 and 46 closed out, a net change of -14 holders.
- The largest Cardlytics buyer in Q2 2021 was Wellington Management Group, an estimated $142M added.
- The largest Cardlytics seller in Q2 2021 was Wells Fargo, an estimated $45.7M sold.
Based on aggregated 13F filings for Q2 2021.